Global Bacterial Conjunctivitis Drugs Market to grow at a CAGR of 2.77% during the period 2016 - 2020; Finds New Report

Report forecast the global bacterial conjunctivitis drugs market to grow at a CAGR of 2.77% during the period 2016-2020.

Bacterial conjunctivitis, which affects either one or both the eyes, is an extremely contagious eye condition wherein the conjunctiva is infected. Staphylococci, streptococci, gonococci, and Chlamydia are some of the causative agents of bacterial conjunctivitis. Extremely pathogenic bacteria such as Chlamydia trachomatis and Neisseria gonorrhea cause severe bacterial conjunctivitis. Antibiotics help in eradicating the microbes, resulting in faster clearance of the symptoms.

Broad-spectrum antibiotics such as Besivance, Zymaxid, Maxitrol, and AzaSite, in the form of antibiotic pills, ointment, or eye drops help treat the infection. Fluoroquinolones, macrolides, aminoglycosides, and phenicols are among the different classes of antibiotics that are commonly prescribed to treat the condition.

The report covers the present scenario and the growth prospects of the global bacterial conjunctivitis drugs market for 2015-2020. To calculate the market size, it considers revenue generated from the sales of branded and generic drugs along with over-the-counter (OTC) drugs used to treat bacterial conjunctivitis.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, the rising awareness about conjunctivitis has resulted in an understanding about how to prevent and control the infection. This has been possible because of numerous awareness programs.

Further, the report states that Patent expiries result in the entry of generics, leading to a decline in the sales of branded drugs. The generics are usually just as effective and safe as the original drugs and come with the added advantage of lower costs. This will result in a major decline in the overall revenue of the market.

Global Bacterial Conjunctivitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the Global Bacterial Conjunctivitis Drugs Market: Akorn, Alcon, Allergan and Bausch & Lomb.

Other Prominent Vendors in the market are: Bayer, Daiichi Sankyo, F. Hoffmann-La Roche, InSite Vision, Merck, Nicox, Novartis, Perrigo, Pfizer, Santen Pharmaceutical, Shire and Valeant Pharmaceuticals.

Market driver

• Rising awareness about infections
• For a full, detailed list, view our report

Market challenge

• Patent expiry of drugs
• For a full, detailed list, view our report

Market trend

• Patient assistance programs
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors? 

Spanning over 57 pages and 33 Exhibits “Global Bacterial Conjunctivitis Drugs Market 2016 - 2020” report covers Executive summary, Scope of  the report, Market research methodology, Introduction, Market landscape, Overview: Bacterial conjunctivitis, Pipeline analysis, Antimicrobial resistance, Legislation relating to antibiotic use in US, Market segmentation by drug class, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://mrr.cm/JZv

Related Reports :

Global Dermatophytic Onychomycosis Market 2016-2020 - Visit at - http://mrr.cm/J4k

Global Orthobiologics Market 2016-2020 - Visit at - http://mrr.cm/J4Z